Song Ruijiang, Liu Shuqin, Leong Kam W
Department of Pharmacology and Molecular Biology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mol Ther. 2007 May;15(5):1007-15. doi: 10.1038/mt.sj.6300129. Epub 2007 Mar 13.
Transfection of DNA vaccines with chemokines may recruit dendritic cells (DCs) locally to capture the antigenic genes and their gene products to generate enhanced CD8(+) cytotoxic T lymphocytes (CTLs). In this study, we investigated the effects of macrophage inflammatory protein (MIP)-1 alpha, MIP-3 alpha, and MIP-3beta on human immunodeficiency virus (HIV) Gag DNA vaccination. The chemokine plasmids markedly enhanced the local infiltration of inflammatory cells and increased the presence of CD11c(+) B7.2(+)-activated DCs. MIP-1 alpha and MIP-3 alpha were potent adjuvants in augmenting CTLs and afforded strong protection to immunized animals against challenge with vaccinia virus expressing Gag (vv-Gag). However, decreased humoral response was observed. MIP-3beta plasmid did not dramatically alter immunity. The chemokine inoculation time with respect to DNA vaccine priming was also investigated. The injection of pMIP-3 alpha three days before Gag plasmid (pGag) vaccination markedly increased specific CTLs compared with simultaneous injection and led to higher protection against vv-Gag. Immunity was also shifted toward a T-helper type-1 (Th1) response. In contrast, inoculation with pMIP-3 alpha three days after pGag vaccination shifted immunity toward a Th2 response. Our data suggest that administration of a chemokine with DNA vaccines offers a valuable strategy to modulate the efficacy and polarization of specific immunity and that chemokine-antigen timing is critical in determining overall biological effects.
用趋化因子转染DNA疫苗可在局部募集树突状细胞(DCs)以捕获抗原基因及其基因产物,从而产生增强的CD8(+)细胞毒性T淋巴细胞(CTLs)。在本研究中,我们调查了巨噬细胞炎性蛋白(MIP)-1α、MIP-3α和MIP-3β对人免疫缺陷病毒(HIV)Gag DNA疫苗接种的影响。趋化因子质粒显著增强了炎性细胞的局部浸润,并增加了CD11c(+) B7.2(+)活化DCs的存在。MIP-1α和MIP-3α是增强CTLs的有效佐剂,并为免疫动物提供了强大的保护,使其免受表达Gag的痘苗病毒(vv-Gag)攻击。然而,观察到体液反应降低。MIP-3β质粒并未显著改变免疫反应。我们还研究了趋化因子接种时间与DNA疫苗启动的关系。与同时注射相比,在接种Gag质粒(pGag)前三天注射pMIP-3α可显著增加特异性CTLs,并对vv-Gag提供更高的保护。免疫反应也转向1型辅助性T细胞(Th1)反应。相反,在pGag接种后三天接种pMIP-3α会使免疫反应转向Th2反应。我们的数据表明,将趋化因子与DNA疫苗联合使用为调节特异性免疫的效力和极化提供了一种有价值的策略,并且趋化因子-抗原接种时间对于确定总体生物学效应至关重要。